Results 181 to 190 of about 13,365 (214)

Subtyping of IPMN

2018
Intraductal papillary mucinous neoplasms (IPMNs) characteristically consist of mucin-filled dilated ducts lined with neoplastic cells forming papillae with a diverse range of morphologies and varying grades of atypia. Based on morphological characteristics and immunohistochemical reaction against mucin proteins, IPMNs are classified into four distinct ...
openaire   +2 more sources

Mucinous Carcinoma and IPMN

2018
Mucin-producing tumors of the pancreas represent a group of premalignant or malignant neoplasms forming multilocular cysts and lined by tall, columnar mucinous epithelium. These tumors are broadly divided into mucinous cystic neoplasms (MCN) and intraductal papillary mucinous neoplasms (IPMN) which have different biologic behavior and pathologic ...
Maria Chiara Ambrosetti, BACCHION, Matilde, Alex Borin, Roberto Pozzi Mucelli   +3 more
openaire   +2 more sources

IPMN as a Premalignant Condition

2021
Due to the overuse of high-quality cross-sectional imaging, such as CT-scan or Magnetic Resonance Imaging (MRI), the prevalence of incidentally discovered pancreatic cystic neoplasms has dramatically risen. Among pancreatic cysts, intraductal papillary mucinous neoplasms of the pancreas (IPMNs) have a prevalence ranging from 20% to 80% of cases.
A. Balduzzi, S. Andrianello, R. Salvia, Giovanni Marchegiani   +3 more
openaire   +1 more source

PGE2 in Pancreatic Cyst Fluid Helps Differentiate IPMN from MCN and Predict IPMN Dysplasia

Journal of Gastrointestinal Surgery, 2008
Current management of intraductal papillary mucinous neoplasm (IPMN) according to recently published International Consensus Guidelines depends upon distinguishing it from mucinous cystic neoplasms (MCNs). We have previously shown that prostaglandin E(2) (PGE(2)) is increased in pancreatic cancer tissue over normal controls.
C Max, Schmidt, Michele T, Yip-Schneider, Matthew C, Ralstin, Sabrina, Wentz, John, DeWitt, Stuart, Sherman, Thomas J, Howard, Lee, McHenry, Sarah, Dutkevitch, Michael, Goggins, Attila, Nakeeb, Keith D, Lillemoe   +11 more
openaire   +2 more sources

IPMN

2012
workshop
Op De Beeck B, D'ONOFRIO, Mirko
openaire   +1 more source

Follow-up Strategy for IPMN

2012
Context IPMNs can be surgically treated or managed conservatively. Objectives To evaluate the effectiveness of the follow-up strategy for IPMN. Methods From January 2003 to June 2012, data regarding 184 patients with IPMNs, as well as type of management (surgery or follow-up), were recorded in a prospective database.
TAFFURELLI, GIOVANNI, D’Ambra M, Pacilio CA, BUSCEMI, SALVATORE, PERI, EUGENIA, MONARI, FRANCESCO, Ricci C, PEZZILLI, RAFFAELE, CALCULLI, LUCIA, SANTINI, DONATELLA, CASADEI, RICCARDO, MINNI, FRANCESCO   +11 more
openaire   +2 more sources

Intraductal Papillary Mucinous Neoplasm (IPMN)

2014
Intraductal papillary mucinous neoplasms (IPMNs) are a group of exocrine mucin-producing tumors, diagnosed at a mean age of 60 years, with male prevalence.
Morana, Giovanni, D'Onofrio, Mirko, Martini, Paolo Tinazzi, De Robertis, Riccardo, Beleù, Alessandro, Luchini, Claudio, Bardhi, Eda, Cardobi, Nicolò, Capelli, Paola   +8 more
openaire   +2 more sources

Fallbericht IPMN

Zeitschrift für Gastroenterologie, 2014
K Rehme, J Christ, M Dauer
openaire   +1 more source

3.0-T magnetic resonance imaging in predicting subtypes of IPMN and invasive IPMN

2015
Purpose Methods and materials Results Conclusion Personal information ...
openaire   +1 more source

Intraductal Papillary Mucinous Neoplasm (IPMN) and IPMN with Associated Invasive Component

2021
Martin Wartenberg, Eva Karamitopoulou-Diamantis   +1 more
openaire   +1 more source